JAPAN – Moderna Inc. has struck a deal to buy OriCiro Genomics K.K., a pioneer in cell-free DNA synthesis and amplification technologies, for US$85 million in cash. The biotechnology company…
Read MoreTag: gene therapy
BioMarin prices its hemophilia gene therapy at about US$1.5M following European approval
USA- California-based biotechnology company BioMarin has announced that European regulators have approved its gene treatment for hemophilia and given it the go-ahead for commercialization. The medication, often known as Roctavian,…
Read MoreOvid Therapeutics seeks out a gene therapy startup to restore its medicine supply
USA- Ovid Therapeutics has teamed up with the startup Gensaic to deliver genetic medicines that would result in new treatments for the treatment of brain disorders. The New York biotech…
Read More